Observational studyBMC cardiovascular disorders2026
A new diagnostic prediction model for infective endocarditis based on the 2023 duke-international society for cardiovascular infectious disease criteria: a multicenter observational study.
Observational study in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundInfective endocarditis (IE) remains a diagnostically challenging disease with diverse symptoms. Whether IE is suspected frequently depends on clinical judgement. A reliable model to estimate the likelihood of IE at presentation across clinical departments is needed; however, no such model is currently available. We aimed to develop such a diagnostic prediction model using objective and reproducible variables and to validate its performance.
methodsWe included inpatients aged ≥ 20 years who had either a diagnosis code for IE or for undiagnosed fever during hospitalization. The model was developed using data from a single university hospital between 2007 and 2017 (derivation cohort) and validated with data from four university hospitals between 2018 and 2020 (validation cohort). IE was diagnosed according to the 2023 Duke-International Society for Cardiovascular Infectious Diseases (ISCVID) criteria. Variables were selected using the Boruta algorithm and Least Absolute Shrinkage and Selection Operator regression. Multivariable logistic regression analysis was used to estimate odds ratios and 95% confidence intervals and to construct the model. Model performance was assessed in both cohorts using the area under the curve (AUC). In the validation cohort, calibration was also assessed using the calibration slope, Hosmer–Lemeshow test, and stratified likelihood ratio.
resultsThe derivation and validation cohorts included 105 (46 IE) and 286 (106 IE) patients, respectively. Predictors in the final model were the presence of a cardiac murmur, log-transformed platelet count, neutrophil percentage, presence of pleural effusion, and a quick sequential [sepsis-related] organ failure assessment score ≥ 2. The AUC was 0.918 in the derivation cohort. In the validation cohort, the AUC was 0.859, with a Hosmer– Lemeshow test p-value of 0.246 and a calibration slope of 0.759. The stratified likelihood ratio ranged from 0.04 to 9.71 and increased with higher model scores.
conclusionsThis model showed high discrimination and good calibration using objective variables that are readily available early after admission. Furthermore, this is the first model to predict IE based on the 2023 Duke-ISCVID criteria. Further multicenter validation in community hospitals would enhance generalizability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.